Skip to main content

Advertisement

Fig. 2 | Cancer Communications

Fig. 2

From: Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients

Fig. 2

Comparison of the prognosis of gallbladder carcinoma patients between the conventional chemotherapy group and the mini-PDX-guided chemotherapy group. The 12 gallbladder carcinoma patients who received agents based on the mini-PDX results had higher overall survival (a) and disease-free survival rates (b) than the 45 gallbladder carcinoma patients treated with conventional chemotherapeutic drugs. b The two curves were compared using log-rank test

Back to article page